Viewing Study NCT07281157


Ignite Creation Date: 2025-12-24 @ 6:58 PM
Ignite Modification Date: 2026-01-02 @ 8:39 AM
Study NCT ID: NCT07281157
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-12-15
First Post: 2025-12-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Irinotecan Liposome Plus Capecitabine and Enronsubemab Combined With Short-course Radiotherapy for Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Sponsor: Tianjin Medical University Cancer Institute and Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module